CooperVision buys EnsEyes to accelerate specialty contact lens growth in Nordic countries

CooperVision announced today that it acquired EnsEyes, a supplier of orthokeratology and scleral contact lenses.

The San Ramon, California-based company said the acquisition of EnsEyes will help accelerate the growth of specialty lens adoption across the Nordic markets.

EnsEyes, with headquarters in Kolding, Denmark, has partners in Denmark as well as Sweden, Norway and Finland, providing customized lenses and professional education.

The newly acquired company will operate within CooperVision’s Specialty EyeCare group. EnsEyes founder Esben Nørregaard Sørensen, a former CooperVision executive, will remain with the company.

Financial terms for the acquisition were not disclosed.

“We have collaborated with EnsEyes for years, including its use of MyProcornea for lens ordering,” CooperVision Specialty EyeCare President Juan Carlos Aragón said in a news release. “Joining CooperVision will give its highly respected team more res…

Read more
  • 0

CooperVision gains CE mark for kids’ myopia contact lens

CooperVision (NYSE:COO) announced today that its DreamLite night contact lenses received CE mark approval for children with myopia.

San Ramon, Calif.-based CooperVision designed its DreamLite night lenses to slow the progression of myopia in children with a refraction of -0.75 D to -5.00 D and a cylindrical refraction with a maximum of -2.50 D, according to a news release.

The company touted a two-year study of DreamLite that demonstrated reduced axial length growth by 63% among high myopes in DreamLite night lenses when compared to the single-vision spectacle lens control group.

DreamLite night lenses are now available across Europe with the CE mark and are also for sale in the Middle East and in China, CooperVision said.

“Myopia’s increasing frequency and prevalence is one of the most discussed issues in eye health. But conversation without action will not change the lives of the hundreds of millions of children affected by the issue. That senti…

Read more
  • 0

DTW Podcast: Vizient on PPE, Vicarious on VR-aided robotics and let’s all hope for pumpernickel

This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical.

Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He’ll also reveal when the company expects to see US hospitals running at pre-COVID levels. Hint: It’ll be a while.

Adam Sachs, CEO of Vicarious Surgical, tells us how the company will put a new round of capital from high-powered investors including Bill Gates and Vinod Khosla to work in developing to develop a surgical system employing robotic and virtual reality technologies. How does the start-up expect to compete with the established leaders in the robotics space?

Co-host Chris Newmarker, executive editor, life sciences, will walk us through the five biggest newsmakers on the MassDevice site involving C.R. Bard, Theranos, and Medtronic. Number one may surprise you, but given the time, perhaps …

Read more
  • 0

The top 5 MassDevice stories of the week — August 14, 2020

COVID-19 continues to batter medical device companies — not to mention the world as a whole. But some of this week’s top five MassDevice stories demonstrate that medtech companies continue to innovate and ink business deals as they look toward a post-pandemic future.

Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five:

5. Federal appeals court rejects preemption argument from BD’s Bard

The 9th U.S. Circuit Court of Appeals handed down an important medical device preemption opinion as it affirmed a $3.6 million award against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard in a bellwether lawsuit case over inferior vena cava filters. Read the full story. 

4. Theranos founder Elizabeth Holmes’ trial to start in March

Ex-Theranos CEO Elizabeth Holmes’ federal fraud trial will now start in Ma…

Read more
  • 0

CooperVision acquires GP Specialists

CooperVision (NYSE:COO) announced that it acquired customized orthokeratology contact lens manufacturer and distributor GP Specialists for an undisclosed amount.

San Ramon, Calif.-based CooperVision said in a news release that the acquisition expands its specialty eye care business and its leadership in addressing myopia.

GP Specialists’ portfolio of ortho-k lenses include the iSee design and the OK-GOV series brands, along with OrthoTool’s designs. CooperVision said GP will also carry on as a distributor of Paragon CRT lenses.

Along with CooperVision’s other specialty eye care entities, GP Specialists will retain its name and operate as a complementary business with its headquarters in San Diego.

GP’s former president, Steve Wagner, will serve as a consultant to the company over the next several months to assist with the transition, while Mark Cosgrove will remain as GP’s GM with responsibilities centering around dai…

Read more
  • 0